SecBot SecBot
SECBOTREPLAY Home › Report › NUVL

NUVL · Nuvalent's Chief Scientific Officer, Henry E

Nuvalent, Inc. · CLUSTER filed Mar 5, 2026 at 19:00 ET

At the news

NEUTRALIMPACT 4/10

CLUSTER filed Mar 5, 2026 at 19:00 ET

Nuvalent's Chief Scientific Officer, Henry E. Pelish, sold 24,993 shares in open-market transactions over two days, realizing approximately $2.44 million in proceeds. The sales were accompanied by the exercise of derivative securities for 16,912 shares, with minimal cash outlay. The total open-market sell value represents a small fraction of Nuvalent's $7.7B market cap.

  • Chief Scientific Officer Henry E. Pelish sold 24,993 shares in open-market transactions on March 12 and 13, 2026, for total proceeds of $2,444,145.87.
  • Pelish also exercised derivative securities for 16,912 shares, with a nominal cost of $160,072.08 and one tranche at $0 (non-cash).
  • Total open-market sale value: ~$2.44M, representing 0.03% of Nuvalent’s $7.7B market cap.
  • All transactions were reported on Form 4 and appear to be part of a pre-arranged trading plan or portfolio diversification.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access